339 related articles for article (PubMed ID: 24329854)
1. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
[TBL] [Abstract][Full Text] [Related]
2. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
[TBL] [Abstract][Full Text] [Related]
3. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
5. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
6. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
Smyth BP; Barry J; Keenan E
Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
[TBL] [Abstract][Full Text] [Related]
7. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
8. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
[TBL] [Abstract][Full Text] [Related]
9. The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.
Gillies M; Palmateer N; Hutchinson S; Ahmed S; Taylor A; Goldberg D
BMC Public Health; 2010 Nov; 10():721. PubMed ID: 21092300
[TBL] [Abstract][Full Text] [Related]
10. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
11. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.
Mathei C; Shkedy Z; Denis B; Kabali C; Aerts M; Molenberghs G; Van Damme P; Buntinx F
J Viral Hepat; 2006 Aug; 13(8):560-70. PubMed ID: 16901287
[TBL] [Abstract][Full Text] [Related]
15. Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs.
Heimer R; Binka M; Koester S; Grund JC; Patel A; Paintsil E; Lindenbach BD
J Infect Dis; 2018 Jan; 217(3):466-473. PubMed ID: 28968665
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
[TBL] [Abstract][Full Text] [Related]
17. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
18. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
19. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
Kemp R; Miller J; Lungley S; Baker M
N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection among injecting drug users in the Czech Republic -- prevalence and associated factors.
Zabransky T; Mravcik V; Korcisova B; Rehak V
Eur Addict Res; 2006; 12(3):151-60. PubMed ID: 16778436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]